BioHarvest Sciences said its board has authorized a share repurchase program under a normal course issuer bid, in line with Canadian market practices. Under the program, the company may repurchase up to 5% of its outstanding common shares, or a maximum of 1,133,392 shares. The normal course issuer bid is expected to begin no earlier than five days after the announcement and will remain in effect for up to 12 months, unless the maximum number of shares is repurchased or the company terminates the program earlier.
BioHarvest Sciences Inc. Common StockBoard authorized a share buyback of up to 1,133,392 shares (5% of outstanding), a positive capital/valuation event.
